CAXTON CORP 13D and 13G filings for Xeris Biopharma Holdings, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 12:15 pm Sale | 2022-12-31 | 13G | Xeris Biopharma Holdings, Inc. XERS | CAXTON CORP | 5,973,324 4.400% | -1,856,358 (-23.71%) | Filing |
| 2022-01-05 12:38 pm Purchase | 2021-10-05 | 13G | Xeris Biopharma Holdings, Inc. XERS | CAXTON CORP | 7,829,682 5.700% | 7,829,682 (New Position) | Filing |